Literature DB >> 663977

An exchange assay for the cytoplasmic glucocorticoid receptor in the liver of the rat.

W Rosner, T Polimeni.   

Abstract

Cytosolic receptor for glucocorticoids can exist in either the free or bound form; assays now in use measure only the free form. In order to assay the total glucocorticoid receptor content of rat liver, free plus bound, we have developed an exchange assay wherein specifically bound [3H]dexamethasone is shown to be a valid measure of receptor in the presence of high concentrations of corticosterone. The exchange between [3H]dexamethasone and corticosterone is able to proceed because, unter the conditions of the assay, corticosterone is almost completely metabolized.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 663977     DOI: 10.1016/0039-128x(78)90054-5

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  5 in total

1.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

Authors:  J Carlstedt-Duke; M Brönnegård; B Strandvik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Rapid, high temperature exchange assay for the hepatic glucocorticoid receptor.

Authors:  J R Hubbard; A Shirwany; M Kalimi
Journal:  Mol Cell Biochem       Date:  1985-01       Impact factor: 3.396

3.  The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice.

Authors:  M C Gonzalez Deniselle; S L Gonzalez; G G Piroli; A E Lima; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1996-02       Impact factor: 5.046

4.  Hepatic estrogen and androgen receptors and binding proteins in streptozotocin-diabetic male Wistar rats.

Authors:  D R Smith; M R Rodway; W A Haniak; G D Bellward
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

5.  Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom.

Authors:  M Brönnegård; S Werner; J A Gustafsson
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.